Skip to main content
. 2018 Feb 21;2(4):370–380. doi: 10.1182/bloodadvances.2018015875

Figure 1.

Figure 1.

Molecular signature in 75 patients with blast phase MPN. (A) stratification headed by driver mutations followed by most frequent mutations. (B) Stratification headed by mutations that are overrepresented compared with historical data on chronic phase disease.